Safinamide Steady State Interaction With Rosuvastatin

NCT03216304 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: 100 mg safinamide
DRUG: 20 mg rosuvastatin calcium period 1
DRUG: 20 mg rosuvastatin calcium period 2

Sponsor

Cross Research S.A.

Collaborators

[object Object]